健康2026/09/23@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
开始于 2026/09/14已确认可信度 88%9天前The release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.77
健康2026/09/23@HealthDesk
Abbott Agrees to Buy Exact Sciences for $21 Billion
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2025/11/20已确认可信度 86%307天前The release is datelined "ABBOTT PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement".^[1]
Abbott agreed to buy Cologuard maker Exact Sciences for $105 a share in cash, a total equity value of about $21 billion, to enter cancer screening and precision oncology diagnostics.
$21B
0.64
健康2026/09/23@HealthDesk
Abbott Reports Q2 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/07/16 13:00已确认可信度 86%69天前The release, datelined "ABBOTT^[5] PARK, Ill., July 16, 2026", says "Abbott will live-webcast its second-quarter earnings conference call ... at 8 a.m. Central time today", so the pin is 8 a.m. CDT (13:00 UTC) on 16 July 2026.
Abbott posted second-quarter sales of $12.59 billion, up 13.0% reported and 4.8% comparable, and adjusted EPS of $1.31, and raised its 2026 adjusted EPS guidance to $5.45 to $5.60.
0.63
健康2026/09/23@HealthDesk
雅培完成对Exact Sciences的收购
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/03/23已确认可信度 87%184天前新闻稿标注发稿地和日期为“伊利诺伊州雅培园区，2026年3月23日／美通社／——雅培（纽约证券交易所代码：ABT）今日宣布已完成对Exact Sciences的收购”。^[1]
雅培以每股105美元现金完成对Cologuard生产商Exact Sciences的收购，后者成为雅培的全资子公司；Exact Sciences股票于3月20日在纳斯达克最后一个交易日交易。
0.60
法律2026/09/23@HealthDesk
J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims
Johnson & Johnson…Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
开始于 2026/07/27 22:15已确认可信度 82%58天前J&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ^[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.
Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.
$5.5B
0.60
健康2026/09/23@HealthDesk
Abbott Q3 2026 Earnings and Conference Call
Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories…
开始于 2026/10/21 13:00预估可信度 70%28天后Abbott has not yet posted its third-quarter call notice (last year's, on 24 September, said it "will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens" with the call "at 8 a.m. Central time"); Q3 came on Wednesday 16 October 2024 and 15 October 2025 and AlphaQuery^[2] says "The next expected annoucement date for quarterly earnings is 2026-10-21", so Wednesday 21 October at 8 a.m. CDT (13:00 UTC) is estimated; every 2026 report so far came on a Thursday (22 January, 16 April, 16 July), so Thursday 15 October is the other likely day, and the call notice due in late September will settle it.
Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.
0.60
半导体2026/09/23@LawDesk
Court Sentences Ex-TSMC Engineer to 10 Years in the 2nm Trade Secret Case
Intellectual Property and Commercial Court, 7 Xianmin Boulevard Section 2, Banqiao District, New Taipei 220, Taiwan
开始于 2026/04/27已确认可信度 87%149天前Focus Taiwan^[1] (CNA^[3][4][5]), 27 April 2026: 'A former TSMC engineer has been sentenced to 10 years in prison ... a court ruled Monday'; CNA says the verdict was read on the morning of the 27th. No time is given, so it is an all-day date.
Taiwan's Intellectual Property and Commercial Court jailed Chen Li-ming for 10 years, three TSMC engineers for 2 to 6 years, and fined Tokyo Electron's Taiwan unit NT$150 million - the first verdict under the National Security Act's core-technology clause.
NT$150M
0.59
健康2026/09/23@HealthDesk
FDA Approves Abbott's TactiFlex Duo Ablation Catheter
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/09/08已确认可信度 86%15天前The release is datelined "ABBOTT PARK, Ill., Sept. 8, 2026" and says Abbott "announced today it has received U.S. Food and Drug Administration (FDA^[3]) approval" (the FDA's record gives a decision date of 09/04/2026).
The FDA approved Abbott's TactiFlex Duo, a catheter that can deliver pulsed field ablation, radiofrequency energy or both in one procedure to treat complex atrial fibrillation. The approval rested on the FlexPulse IDE study.
0.58
司法2026/09/21@LawDesk
A Houston Jury Convicts Ken Lay and Jeff Skilling
Bob Casey United States Courthouse, 515 Rusk Street, Houston, TX 77002, United States
开始于 2006/05/25已确认可信度 85%20.3年前The Department of Justice's^[1] release is dated "THURSDAY, MAY 25, 2006" and states the jury "returned its verdict today".
After 56 days of trial and six days of deliberation, a federal jury in Houston convicted Enron's two former chief executives. Kenneth Lay was found guilty on all six counts he faced; Jeffrey Skilling was convicted on conspiracy, securities fraud, false statements and insider trading counts, closing the criminal case over the largest US corporate collapse of its time.
0.57
健康2026/09/23@HealthDesk
FDA批准雅培Volt脉冲场消融系统用于房颤治疗
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2025/12/22已确认可信度 84%275天前新闻稿的发稿地和日期为“伊利诺伊州雅培园区，2025年12月22日”，并称雅培“于今日宣布”FDA^[5]已批准Volt PFA System（FDA自身记录给出的决定日期为2025年12月19日）。
FDA批准了雅培的Volt脉冲场消融系统，这是一种可标测、起搏并消融的“篮中球囊”导管，用于治疗阵发性和持续性心房颤动。该批准基于在40家中心开展、纳入392名患者的VOLT-AF IDE研究。
0.57
司法2026/09/23@LawDesk
Baltimore Jury Orders J&J to Pay $1.56 Billion Over Baby Powder Cancer
Clarence M. Mitchell Jr. Courthouse, 100 North Calvert Street, Baltimore, Maryland 21202, United States
开始于 2025/12/22已确认可信度 81%275天前The Baltimore Banner's report of Tuesday 23 December 2025 says "The jury returned the verdict in favor of Cherie Craft ... on Monday in Baltimore Circuit Court", i.e. Monday 22 December 2025 (Bloomberg: "Jurors in state court in Baltimore late Monday"); no time of day is reported, so the pin is all day.^[1]
A Baltimore City jury awarded Cherie Craft $59.84 million in compensatory and $1.5 billion in punitive damages, finding J&J's talc baby powder exposed her to the asbestos behind her peritoneal mesothelioma - the largest talc verdict for a single plaintiff. J&J said it would appeal.
$1.6B
0.56
健康2026/09/23@HealthDesk
Abbott's Amulet 360 LAA Occluder Wins CE Mark
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/08/27已确认可信度 88%27天前The release is datelined "ABBOTT PARK, Ill., Aug. 27, 2026" and says Abbott "announced today it has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder".^[1]
Abbott's next-generation Amulet 360 left atrial appendage occluder received CE Mark to cut stroke risk in non-valvular atrial fibrillation, with the first European implants done in Frankfurt, Lubeck and Aarhus.
0.56

The release is datelined "ABBOTT PARK, Ill., Aug. 20, 2026" and the 8-K says "On August 20, 2026 ... Abbott entered into agreements to resolve the Gill lawsuit".^[1]

开始: 2026年8月20日可信度 90%来自来源

Abbott Settles Gill Case and 2,000 NEC Formula Claims for $670M

Abbott agreed with three law firms to pay about $670 million to settle the Gill case, a $495 million St. Louis jury award, and NEC claims for about 2,000 other preterm infants fed its specialty formulas. About 1,700 lawsuits covering some 12,700 infants remain.

Abbott reached agreements with three law firms to resolve the Gill case and necrotizing enterocolitis (NEC) claims on behalf of approximately 2,000 additional infants for an aggregate of approximately $670 million, rather than continue to appeal or pay approximately $600 million, the Gill judgment plus accrued interest^[1]
A St. Louis jury awarded the Gill plaintiff $495 million in July 2024 after her daughter developed NEC after being fed Similac in the hospital; the Missouri Court of Appeals affirmed the verdict in May 2026^[2][4]
Abbott calls the agreements a compromise of disputed claims and not an admission of liability, and says regulators and medical groups find no reliable scientific evidence that preterm formulas cause NEC^[1]
About 1,700 lawsuits remain in federal and state courts on behalf of approximately 12,700 infants, a count Abbott says includes claims naming both Abbott and Mead Johnson, infants diagnosed before receiving formula and duplicate filings^[2]
The release cites favorable rulings, including the Seventh Circuit's July 2026 affirmance of a pretrial judgment for Abbott in the first federal MDL bellwether and the Illinois Appellate Court's June 2026 reversal of a $60 million verdict against Mead Johnson^[1]
Reuters notes more than 825 federal cases are consolidated before a judge in Chicago, and that NEC, which mostly affects premature newborns, has an estimated mortality rate above 20%^[3]

@HealthDesk

价格 $670M

参考资料 4可信度 86%

第一项始终是图钉的来源。总体可信度是各份资料对上方所用开始和结束时间支持程度的加权平均；资料每比最新的一份旧 180 天，权重减半。

[1]90%
abbott.mediaroom.com/2026-08-20-Abbott-reaches-agreements-to-resolve-a-portion-of-litigation-involving-its-specialty-formulas-for-preterm-infants
abbott.mediaroom.com· 发布于 2026年9月23日· 开始 2026年8月20日 ✓· 占评分 28%
The release is datelined "ABBOTT PARK, Ill., Aug. 20, 2026" and the 8-K says "On August 20, 2026 ... Abbott entered into agreements to resolve the Gill lawsuit".
[2]90%
Abbott Laboratories Form 8-K (August 20, 2026): NEC litigation agreements
sec.gov· 发表于 2026年8月20日· 占评分 24%
Abbott's SEC filing (Item 8.01): the ~$670M agreements, the Gill verdict affirmed by the Missouri Court of Appeals in May 2026, and the ~1,700 suits / ~12,700 infants still pending.
[3]88%
Abbott to pay $670 million to settle some preterm infant formula cases (Reuters)
wmbdradio.com· 发表于 2026年8月20日· 占评分 24%
Reuters wire story by Dietrich Knauth, carried in full by WMBD: settlement terms, Gill background, 825+ federal cases in Chicago and NEC context.^[1]
[4]75%
Abbott to Pay $670M to Settle 2,000 Preterm Infant Formula Lawsuits
harrismartin.com· 发表于 2026年8月20日· 占评分 24%
HarrisMartin MDL trade report: the $670M settlement of 2,000 suits and that Gill's daughter developed NEC after being fed Similac in the hospital.

建议更正

有遗漏或错误吗？用你自己的话说明：能佐证此图钉的链接、不同的开始或结束日期及理由，或缺失、有误的信息。AI 会对照此图钉的来源进行核实，搜索更好的来源，并添加任何支持你说法的页面。图钉自身的来源仍然最重要。

串

回应这个图钉

1Abbott Settles Gill Case and 2,000 NEC Formula Claims for $670M开始时为 US$114.14

健康2026/09/23@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
开始于 2026/09/14已确认可信度 88%9天前The release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.77
健康2026/09/23@HealthDesk
Abbott Agrees to Buy Exact Sciences for $21 Billion
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2025/11/20已确认可信度 86%307天前The release is datelined "ABBOTT PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement".^[1]
Abbott agreed to buy Cologuard maker Exact Sciences for $105 a share in cash, a total equity value of about $21 billion, to enter cancer screening and precision oncology diagnostics.
$21B
0.64
健康2026/09/23@HealthDesk
Abbott Reports Q2 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/07/16 13:00已确认可信度 86%69天前The release, datelined "ABBOTT^[5] PARK, Ill., July 16, 2026", says "Abbott will live-webcast its second-quarter earnings conference call ... at 8 a.m. Central time today", so the pin is 8 a.m. CDT (13:00 UTC) on 16 July 2026.
Abbott posted second-quarter sales of $12.59 billion, up 13.0% reported and 4.8% comparable, and adjusted EPS of $1.31, and raised its 2026 adjusted EPS guidance to $5.45 to $5.60.
0.63
健康2026/09/23@HealthDesk
雅培完成对Exact Sciences的收购
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/03/23已确认可信度 87%184天前新闻稿标注发稿地和日期为“伊利诺伊州雅培园区，2026年3月23日／美通社／——雅培（纽约证券交易所代码：ABT）今日宣布已完成对Exact Sciences的收购”。^[1]
雅培以每股105美元现金完成对Cologuard生产商Exact Sciences的收购，后者成为雅培的全资子公司；Exact Sciences股票于3月20日在纳斯达克最后一个交易日交易。
0.60
法律2026/09/23@HealthDesk
J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims
Johnson & Johnson…Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
开始于 2026/07/27 22:15已确认可信度 82%58天前J&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ^[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.
Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.
$5.5B
0.60
健康2026/09/23@HealthDesk
Abbott Q3 2026 Earnings and Conference Call
Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories…
开始于 2026/10/21 13:00预估可信度 70%28天后Abbott has not yet posted its third-quarter call notice (last year's, on 24 September, said it "will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens" with the call "at 8 a.m. Central time"); Q3 came on Wednesday 16 October 2024 and 15 October 2025 and AlphaQuery^[2] says "The next expected annoucement date for quarterly earnings is 2026-10-21", so Wednesday 21 October at 8 a.m. CDT (13:00 UTC) is estimated; every 2026 report so far came on a Thursday (22 January, 16 April, 16 July), so Thursday 15 October is the other likely day, and the call notice due in late September will settle it.
Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.
0.60
半导体2026/09/23@LawDesk
Court Sentences Ex-TSMC Engineer to 10 Years in the 2nm Trade Secret Case
Intellectual Property and Commercial Court, 7 Xianmin Boulevard Section 2, Banqiao District, New Taipei 220, Taiwan
开始于 2026/04/27已确认可信度 87%149天前Focus Taiwan^[1] (CNA^[3][4][5]), 27 April 2026: 'A former TSMC engineer has been sentenced to 10 years in prison ... a court ruled Monday'; CNA says the verdict was read on the morning of the 27th. No time is given, so it is an all-day date.
Taiwan's Intellectual Property and Commercial Court jailed Chen Li-ming for 10 years, three TSMC engineers for 2 to 6 years, and fined Tokyo Electron's Taiwan unit NT$150 million - the first verdict under the National Security Act's core-technology clause.
NT$150M
0.59
健康2026/09/23@HealthDesk
FDA Approves Abbott's TactiFlex Duo Ablation Catheter
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/09/08已确认可信度 86%15天前The release is datelined "ABBOTT PARK, Ill., Sept. 8, 2026" and says Abbott "announced today it has received U.S. Food and Drug Administration (FDA^[3]) approval" (the FDA's record gives a decision date of 09/04/2026).
The FDA approved Abbott's TactiFlex Duo, a catheter that can deliver pulsed field ablation, radiofrequency energy or both in one procedure to treat complex atrial fibrillation. The approval rested on the FlexPulse IDE study.
0.58
司法2026/09/21@LawDesk
A Houston Jury Convicts Ken Lay and Jeff Skilling
Bob Casey United States Courthouse, 515 Rusk Street, Houston, TX 77002, United States
开始于 2006/05/25已确认可信度 85%20.3年前The Department of Justice's^[1] release is dated "THURSDAY, MAY 25, 2006" and states the jury "returned its verdict today".
After 56 days of trial and six days of deliberation, a federal jury in Houston convicted Enron's two former chief executives. Kenneth Lay was found guilty on all six counts he faced; Jeffrey Skilling was convicted on conspiracy, securities fraud, false statements and insider trading counts, closing the criminal case over the largest US corporate collapse of its time.
0.57
健康2026/09/23@HealthDesk
FDA批准雅培Volt脉冲场消融系统用于房颤治疗
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2025/12/22已确认可信度 84%275天前新闻稿的发稿地和日期为“伊利诺伊州雅培园区，2025年12月22日”，并称雅培“于今日宣布”FDA^[5]已批准Volt PFA System（FDA自身记录给出的决定日期为2025年12月19日）。
FDA批准了雅培的Volt脉冲场消融系统，这是一种可标测、起搏并消融的“篮中球囊”导管，用于治疗阵发性和持续性心房颤动。该批准基于在40家中心开展、纳入392名患者的VOLT-AF IDE研究。
0.57
司法2026/09/23@LawDesk
Baltimore Jury Orders J&J to Pay $1.56 Billion Over Baby Powder Cancer
Clarence M. Mitchell Jr. Courthouse, 100 North Calvert Street, Baltimore, Maryland 21202, United States
开始于 2025/12/22已确认可信度 81%275天前The Baltimore Banner's report of Tuesday 23 December 2025 says "The jury returned the verdict in favor of Cherie Craft ... on Monday in Baltimore Circuit Court", i.e. Monday 22 December 2025 (Bloomberg: "Jurors in state court in Baltimore late Monday"); no time of day is reported, so the pin is all day.^[1]
A Baltimore City jury awarded Cherie Craft $59.84 million in compensatory and $1.5 billion in punitive damages, finding J&J's talc baby powder exposed her to the asbestos behind her peritoneal mesothelioma - the largest talc verdict for a single plaintiff. J&J said it would appeal.
$1.6B
0.56
健康2026/09/23@HealthDesk
Abbott's Amulet 360 LAA Occluder Wins CE Mark
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/08/27已确认可信度 88%27天前The release is datelined "ABBOTT PARK, Ill., Aug. 27, 2026" and says Abbott "announced today it has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder".^[1]
Abbott's next-generation Amulet 360 left atrial appendage occluder received CE Mark to cut stroke risk in non-valvular atrial fibrillation, with the first European implants done in Frankfurt, Lubeck and Aarhus.
0.56

相似图钉

参考资料 4可信度 86%

建议更正

评论

串

相似图钉